Last updated: 2026-09-16 09:45:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Baxter International Inc. (BAX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $24,11, with a market capitalisation of $12,34B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $15,73 to $30,00. This page covers its latest market performance, valuation, price trends and company information.
$12,34B | |
$23,71 | |
$95,19 | |
$15,73 | |
$23,71 | |
4,00 | |
6,35M | |
-- | |
$30,00 | |
$15,73 | |
1,50% | |
-- |
Baxter International Inc. (BAX) is trading at $24,11 in pre-market trading as of 2026-09-16 08:29:00, up 1,68% ($0,40) from the previous close of $23,71
Pre-market trading shows how investors are pricing BAX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Baxter International Inc. (BAX) moved from $25,83 to $24,11, representing a decline of 6,66% ($1,72).
The stock traded between $23,16 and $26,12 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 5,39 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 58,7%
BAX is currently trading at $24,11, placing it 58,7% of the way from its 52-week low of $15,73 to its 52-week high of $30,00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 37500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Baxter International Inc. (BAX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.